The global tissue banking market is evaluated at US$2.454 billion for the year 2020 and is projected to grow at a CAGR of 4.65% to reach a market size of US$3.374 billion by the year 2027.
A tissue bank is considered a certain type of bank that collects fresh specimens and tissue for future needs. The tissue bank is considered one of the leading specimen or tissue storage systems in the world. The medical field and research and development sectors are presently widely seeking the application and help of tissue banks. The need for fresh specimens and tissues in the research and development sector is giving potential to the growth of the global tissue bank market. The market players’ investment in the development and research in the cell and tissue regeneration field are also driving the growth of the global tissue bank market. The medical sector and hospitals are also widely seeking the support and assistance of tissue banks for the treatment of certain chronic disorders. Hospitals and health research institutions relying on tissue banks are boosting the market growth of global tissue banks. The rising cases of chronic diseases like cancer etc. and their treatment based on tissue regeneration are also boosting the market value of tissue banks in the global market. The support offered by governments and government organizations is also contributing to the growth of the global tissue banking market.
The recent outbreak of the COVID-19 pandemic has adversely affected the market growth of the global tissue banking market. The ongoing research and developments conducted on tissues were halted due to the lockdowns and strict COVID-19 restrictions imposed by the government in order to prevent the spread of the coronavirus. The focus of the government and the medical field on preventing COVID spread resulted in less focus on and slow growth of the global tissue banking market in the pandemic period. The limited availability of practitioners and employees in the tissue banking sector also restricted the growth of the global tissue banking market to a certain extent. The high economic crisis that arose due to the COVID-19 pandemic also negatively influenced the economic stability of countries, restricting the growth of the tissue banking sector in each country, as the tissue banking systems have high expenditure and maintenance costs.
The demand for tissues for the treatment of chronic diseases
The rising demand for tissues for treating chronic diseases is increasing the market value of the global tissue banking sector. A tissue bank is a collection of various specimens and fresh tissues and is a relatively new discovery in the medical field that employs tissue for the treatment of chronic diseases and is boosting the growth of the global tissue banking system. According to the "American Association of Tissue Banks", the tissue banking network in the United States is exhibiting steady growth, with approximately 58 accredited tissue banks working in the United States alone. The tissue banks working in the United States are also properly certified and accredited by the FDA (Food and Drug Administration) of the United States. The government of the U.S. has been encouraging the use of tissue banks. According to the report of AATB (American Association of Tissue Banks), blood tissues or blood cells account for the major share of the global tissue banking market. The need for fresh specimens and the tissue in the treatment of chronic disorders and regeneration of tissue cells is driving the growth of the global tissue banking market.
Rising research and development
The growing trend of research and developments in tissue regeneration and the use of tissue in efficiently treating chronic diseases is boosting the growth of the global tissue banking market. Discoveries of stem cells in developing any other tissue is one of the latest innovations in the medical or health research sector. The discoveries like stem cells and others are fuelling the market growth of tissue banking in the global market. The investment of major players like Allergan and Hamilton Companies is boosting the applications and developments in tissue engineering. The wide research and developments in tissue engineering and employing tissue for treating chronic diseases are contributing to the market growth.
North America has the largest market share
Geographically, the North American region is has the largest share in the global tissue banking market. The presence of a large number of tissue banks and increasing research and development in the tissue engineering sector is leading to growth in the North American region in the tissue banking market. The presence of major market players and the rising number of chronic diseases are also driving the market growth in the North American tissue banking market.
| Report Metric | Details |
| Market size value in 2020 | US$2.454 billion |
| Market size value in 2027 | US$3.374 billion |
| Growth Rate | CAGR of 4.65% from 2020 to 2027 |
| Base year | 2020 |
| Forecast period | 2022–2027 |
| Forecast Unit (Value) | USD Billion |
| Segments covered | Tissue Type, Application, And Geography |
| Regions covered | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Companies covered | Hamilton Company, IMA Pharma, Life Link Tissue Bank, Merck KgaA, PHC Europe B.V., Tata Memorial Hospital - Tissue Bank, Tecan Group Ltd., The PXE International Blood and Tissue Bank, Thermo Fisher Scientific, Inc., TuBaFrost Group, Versiti |
| Customization scope | Free report customization with purchase |
Market Segmentation
Frequently Asked Questions (FAQs)
Q1. What will be the tissue banking market size by 2027?
A1. The tissue banking market is projected to reach a total market size of US$3.374 billion in 2027.
Q2. What are the growth prospects for the tissue banking market?
A2. The global tissue banking market is projected to grow at a CAGR of 4.65% during the forecast period.
Q3. What is the size of the global tissue banking market?
A3. Tissue Banking Market was valued at US$2.454 billion in 2020.
Q4. What factors are anticipated to drive the tissue banking market growth?
A4. The need for fresh specimens and tissues in the research and development sector is giving potential to the tissue banking market growth.
Q5. Which region holds the largest market share in the tissue banking market?
A5. Geographically, the North American region holds the largest share in the global tissue banking market owing to the presence of a large number of tissue banks and increasing research and developments in the tissue engineering sector.
1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Global Tissue Banking Market Analysis, by Tissue Type
5.1. Introduction
5.2. Cornea
5.3. Skin
5.4. Bones
5.5. Heart Valves
5.6. Blood
5.7. Soft Tissues
5.8. Umbilical Cord
6. Global Tissue Banking Market Analysis, by Application
6.1. Introduction
6.2. Therapeutic
6.3. Research and development
6.4. Others
7. Global Tissue Banking Market Analysis, by Geography
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. UK
7.4.4. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. India
7.6.3. Japan
7.6.4. South Korea
7.6.5. Taiwan
7.6.6. Thailand
7.6.7. Indonesia
7.6.8. Others
8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. Company Profiles
9.1. Hamilton Company
9.2. IMA Pharma
9.3. Life Link Tissue Bank
9.4. Merck KgaA
9.5. PHC Europe B.V.
9.6. Tata Memorial Hospital - Tissue Bank
9.7. Tecan Group Ltd.
9.8. The PXE International Blood and Tissue Bank
9.9. Thermo Fisher Scientific, Inc.
9.10. TuBaFrost Group
9.11. Versity
Hamilton Company
IMA Pharma
Life Link Tissue Bank
PHC Europe B.V.
Tata Memorial Hospital - Tissue Bank
Tecan Group Ltd.
The PXE International Blood and Tissue Bank
Thermo Fisher Scientific, Inc.
TuBaFrost Group
Versiti
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.